Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

about

Proton-pump inhibitors: understanding the complications and risks.Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.New therapeutic options opened by the molecular classification of gastric cancer.

P2860

Q41996131-A06AD720-DFB5-4BF2-BF1C-56106D98A2CF Q46559661-77A93C0D-2B09-4D07-BBAC-C9ADF9C31BC9 Q55527185-087DBFC6-5492-4291-890B-3725687D5EAE

P2860

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

Item

http://www.wikidata.org/entity/Q38386642

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Association of Proton Pump Inh ...... GiC Randomized Clinical Trial.

@en

type

Item

label

Association of Proton Pump Inh ...... GiC Randomized Clinical Trial.

@en

prefLabel

Association of Proton Pump Inh ...... GiC Randomized Clinical Trial.

@en

P1476

Association of Proton Pump Inh ...... GiC Randomized Clinical Trial.

@en

P2093

Alberto Sobrero

http://www.w3.org/2001/XMLSchema#string

Andrew Scarfe

http://www.w3.org/2001/XMLSchema#string

Dennis Slamon

http://www.w3.org/2001/XMLSchema#string

J Randolph Hecht

http://www.w3.org/2001/XMLSchema#string

Jennifer Spratlin

http://www.w3.org/2001/XMLSchema#string

Julie Price Hiller

http://www.w3.org/2001/XMLSchema#string

Karen Afenjar

http://www.w3.org/2001/XMLSchema#string

Karen King

http://www.w3.org/2001/XMLSchema#string

Karen Mulder

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Clinical pharmacokinetics of capecitabine.

Proton pump inhibitors--differences emerge in hepatic metabolism.

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?

Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?

P304

767-773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2016.3358

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27737436

http://www.w3.org/2001/XMLSchema#string

P932

5824322

http://www.w3.org/2001/XMLSchema#string

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

about

P2860

P2860

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932